Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCKAR - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DACT1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TNFAIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPLP0 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PGM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MNT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IPO4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TLR3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SYNPO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LOC101928269 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EXOC7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EDRF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RC3H1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HLA-DQB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COL6A3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ECM2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OPCML - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BTD - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPOCK1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AFDN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on